Literature DB >> 11704758

Subunits of the translation initiation factor eIF2B are mutant in leukoencephalopathy with vanishing white matter.

P A Leegwater1, G Vermeulen, A A Könst, S Naidu, J Mulders, A Visser, P Kersbergen, D Mobach, D Fonds, C G van Berkel, R J Lemmers, R R Frants, C B Oudejans, R B Schutgens, J C Pronk, M S van der Knaap.   

Abstract

Leukoencephalopathy with vanishing white matter (VWM) is an inherited brain disease that occurs mainly in children. The course is chronic-progressive with additional episodes of rapid deterioration following febrile infection or minor head trauma. We have identified mutations in EIF2B5 and EIF2B2, encoding the epsilon- and beta-subunits of the translation initiation factor eIF2B and located on chromosomes 3q27 and 14q24, respectively, as causing VWM. We found 16 different mutations in EIF2B5 in 29 patients from 23 families. We also found two distantly related individuals who were homozygous with respect to a missense mutation in EIF2B2, affecting a conserved amino acid. Three other patients also had mutations in EIF2B2. As eIF2B has an essential role in the regulation of translation under different conditions, including stress, this may explain the rapid deterioration of people with VWM under stress. Mutant translation initiation factors have not previously been implicated in disease.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11704758     DOI: 10.1038/ng764

Source DB:  PubMed          Journal:  Nat Genet        ISSN: 1061-4036            Impact factor:   38.330


  107 in total

Review 1.  The unfolded protein response in protein aggregating diseases.

Authors:  Alexander Gow; Ramaswamy Sharma
Journal:  Neuromolecular Med       Date:  2003       Impact factor: 3.843

Review 2.  Vanishing white matter disease: an Italian case with A638G mutation in exon 5 of EIF2B2 gene, an unusual early onset and a long course.

Authors:  Luisa Sambati; Raffaele Agati; Antonella Bacci; Silvia Bianchi; Sabina Capellari
Journal:  Neurol Sci       Date:  2012-06-23       Impact factor: 3.307

3.  eIF2B Mutations Cause Mitochondrial Malfunction in Oligodendrocytes.

Authors:  Melisa Herrero; Shir Mandelboum; Orna Elroy-Stein
Journal:  Neuromolecular Med       Date:  2019-05-27       Impact factor: 3.843

4.  Late onset vanishing white matter disease.

Authors:  Axel Riecker; Thomas Nägele; Marco Henneke; Ludger Schöls
Journal:  J Neurol       Date:  2007-03-31       Impact factor: 4.849

5.  Novel infantile-onset leukoencephalopathy with high lactate level and slow improvement.

Authors:  Marjan E Steenweg; Adeline Vanderver; Berten Ceulemans; Prab Prabhakar; Luc Régal; Aviva Fattal-Valevski; Lawrence Richer; Barbara Goeggel Simonetti; Frederik Barkhof; Richard J T Rodenburg; Petra J W Pouwels; Marjo S van der Knaap
Journal:  Arch Neurol       Date:  2012-06

6.  Adult-onset vanishing white matter disease due to a novel EIF2B3 mutation.

Authors:  Roberta La Piana; Adeline Vanderver; Marjo van der Knaap; Louise Roux; Donatella Tampieri; Bernard Brais; Geneviève Bernard
Journal:  Arch Neurol       Date:  2012-06

7.  Invited article: an MRI-based approach to the diagnosis of white matter disorders.

Authors:  Raphael Schiffmann; Marjo S van der Knaap
Journal:  Neurology       Date:  2009-02-24       Impact factor: 9.910

8.  Enhanced integrated stress response promotes myelinating oligodendrocyte survival in response to interferon-gamma.

Authors:  Wensheng Lin; Phillip E Kunkler; Heather P Harding; David Ron; Richard P Kraig; Brian Popko
Journal:  Am J Pathol       Date:  2008-09-25       Impact factor: 4.307

9.  Evaluation of the endoplasmic reticulum-stress response in eIF2B-mutated lymphocytes and lymphoblasts from CACH/VWM patients.

Authors:  Laetitia Horzinski; Liraz Kantor; Aurélia Huyghe; Raphael Schiffmann; Orna Elroy-Stein; Odile Boespflug-Tanguy; Anne Fogli
Journal:  BMC Neurol       Date:  2010-10-19       Impact factor: 2.474

10.  Eukaryotic initiation factor 2B (eIF2B) GEF activity as a diagnostic tool for EIF2B-related disorders.

Authors:  Laetitia Horzinski; Aurélia Huyghe; Marie-Céleste Cardoso; Céline Gonthier; Lemlih Ouchchane; Raphael Schiffmann; Pierre Blanc; Odile Boespflug-Tanguy; Anne Fogli
Journal:  PLoS One       Date:  2009-12-15       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.